Growth Metrics

Integra Lifesciences Holdings (IART) Income from Continuing Operations (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Income from Continuing Operations for 17 consecutive years, with 1704000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 108.77% to 1704000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 516474000.0 through Dec 2025, down 7338.77% year-over-year, with the annual reading at 516474000.0 for FY2025, 7337.7% down from the prior year.
  • Income from Continuing Operations hit 1704000.0 in Q4 2025 for Integra Lifesciences Holdings, up from 5404000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 52946000.0 in Q4 2022 to a low of 484073000.0 in Q2 2025.
  • Historically, Income from Continuing Operations has averaged 5302550.0 across 5 years, with a median of 19665500.0 in 2023.
  • Biggest five-year swings in Income from Continuing Operations: surged 9603.52% in 2021 and later tumbled 3803.18% in 2025.
  • Year by year, Income from Continuing Operations stood at 45384000.0 in 2021, then grew by 16.66% to 52946000.0 in 2022, then plummeted by 62.54% to 19834000.0 in 2023, then dropped by 2.01% to 19435000.0 in 2024, then tumbled by 108.77% to 1704000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for IART at 1704000.0 in Q4 2025, 5404000.0 in Q3 2025, and 484073000.0 in Q2 2025.